190 related articles for article (PubMed ID: 31865754)
1. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
2. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
[TBL] [Abstract][Full Text] [Related]
4. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.
Elbadawi MM; Eldehna WM; Nocentini A; Abo-Ashour MF; Elkaeed EB; Abdelgawad MA; Alharbi KS; Abdel-Aziz HA; Supuran CT; Gratteri P; Al-Sanea MM
Eur J Med Chem; 2021 Jun; 218():113360. PubMed ID: 33773285
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
[TBL] [Abstract][Full Text] [Related]
9. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
Krasavin M; Shetnev A; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Korsakov M; Tennikova TB; Supuran CT
Eur J Med Chem; 2019 Apr; 168():301-314. PubMed ID: 30826507
[TBL] [Abstract][Full Text] [Related]
10. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
11. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms.
Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343
[TBL] [Abstract][Full Text] [Related]
12. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
Genah S; Angeli A; Supuran CT; Morbidelli L
Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
Federici C; Lugini L; Marino ML; Carta F; Iessi E; Azzarito T; Supuran CT; Fais S
J Enzyme Inhib Med Chem; 2016; 31(sup1):119-125. PubMed ID: 27142956
[TBL] [Abstract][Full Text] [Related]
14. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
Koyuncu I; Tülüce Y; Slahaddin Qadir H; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):703-711. PubMed ID: 30810431
[TBL] [Abstract][Full Text] [Related]
16. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
[TBL] [Abstract][Full Text] [Related]
17. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Elimam DM; Eldehna WM; Salem R; Bonardi A; Nocentini A; Al-Rashood ST; Elaasser MM; Gratteri P; Supuran CT; Allam HA
Eur J Med Chem; 2022 Jan; 228():114008. PubMed ID: 34871842
[TBL] [Abstract][Full Text] [Related]
18. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004):
Mishra CB; Mongre RK; Prakash A; Jeon R; Supuran CT; Lee MS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):954-963. PubMed ID: 33947294
[TBL] [Abstract][Full Text] [Related]
19. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity.
Angeli A; Trallori E; Ferraroni M; Di Cesare Mannelli L; Ghelardini C; Supuran CT
Eur J Med Chem; 2018 Sep; 157():1214-1222. PubMed ID: 30193219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]